(1) Upon review of an inquiry response letter described in RCW 69.48.040
(3), the department shall notify the person or entity in writing whether or not the person or entity is considered a covered manufacturer. If the department determines that the person or entity is a covered manufacturer, the written notice will include a warning regarding the penalties for violation of this chapter, as authorized in RCW 69.48.110
(2)(a) Within thirty days after the first full year of a drug take-back program's implementation, and annually thereafter, the department may provide a list of covered manufacturers potentially not participating in a drug take-back program to each approved program operator.
(b) Within thirty days of receiving such a list, approved program operators may provide any comments on the list to the department.
(c) Within thirty days of receiving and considering any approved program operator comments, the department may publish on its web site a list of all covered manufacturers not participating in a drug take-back program.
(3) The department shall remove any covered manufacturer identified in the published list if the covered manufacturer participates in an approved drug take-back program.
[Statutory Authority: RCW 69.48.180
. WSR 19-14-090, § 246-480-030, filed 7/1/19, effective 8/1/19.]